SCHEMBL80456

SCHEMBL80456

NC(=O)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL8519968 0.74
SCHEMBL27323829 0.70
Carbamic Acid SCHEMBL6017120 0.70
Urea SCHEMBL6242741 0.70
SCHEMBL3927405 0.70
SCHEMBL1003846 0.70
Carbamic Acid SCHEMBL27908693 0.67
Urea SCHEMBL5915116 0.67
SCHEMBL9412208 0.67
SCHEMBL3317532 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 673 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3895707-B1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2023-10-04 EP claimed
EP-3896060-B1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2023-08-16 EP claimed
EP-3894402-B1 N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2023-07-05 EP claimed
US-20230042358-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-02-09 US claimed
US-20220169639-A1 N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2022-06-02 US claimed
CN-114040764-A Cyclin-dependent kinase 2 biomarkers and uses thereof 因赛特公司 2022-02-11 CN claimed
US-20220017514-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2022-01-20 US claimed
US-20210380602-A1 NOVEL PYRROLE AND PYRIDONE DERIVATIVES AND USES THEREOF UNIV VIRGINIA COMMONWEALTH (US) 2021-12-09 US claimed
EP-3896060-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2021-10-20 EP claimed
EP-3895707-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2021-10-20 EP claimed
WO-1997016452-A1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1997-05-09 WO claimed
EP-0306833-B1 Silver halide photographic material FUJI PHOTO FILM CO LTD (JP) 1994-01-12 EP claimed
US-5210202-A Chiral phosphorous compounds, a process for their manufacture and their application to the catalysis of enantioselective synthesis reactions SOCIETE CHIMIQUE DES CHARBONNAGES S.A. (FR) 1993-05-11 US claimed
US-4978603-A Developing an emulsion layer containing a rhodium salt and a preferential grain size using a dihydroxy developer, a sulfite and an indazole compound FUJI PHOTO FILM CO., LTD. (JP) 1990-12-18 US claimed
US-4956263-A BLACKAND WHITE PHOTOGRAPHIC FILM CONTAINING CONTAINING A HYDRAZINE DERIVATIVE; HIGH CONTRAST; DAYLIGHT USE; ANTISOILANTS; SAFELIGHT SAFETY FUJI PHOTO FILM CO., LTD. (JP) 1990-09-11 US claimed
EP-0253700-B1 PROCESS FOR THE ASYMMETRIC HYDROGENATION OF CARBONYL COMPOUNDS, AND THE COMPOUNDS OBTAINED THEREBY ELF ATOCHEM S.A. (FR) 1990-08-29 EP claimed
EP-0344990-A1 Mitomycin derivatives and intermediates therefor KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1989-12-06 EP claimed
EP-0326887-A1 Beta-lactam antibiotics, process for their preparation and their use as and in therapeutic agents BAYER AG (DE) 1989-08-09 EP claimed
EP-0306833-A2 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1989-03-15 EP claimed
EP-0136210-A1 Chiral phosphorus ligands, process for their preparation and their use in the catalysis of enantioselective synthesis reactions NORSOLOR S.A. (FR) 1985-04-03 EP claimed